How antipsychotics affect the immune system in psychosis
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how antipsychotic medicines affect the immune system in people with psychosis. By taking blood samples before and after starting or changing medication, researchers hope to understand why some people respond better to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You currently have symptoms of psychosis that need treatment from a mental health team.
- You are about to start a new antipsychotic medicine, switch to a different one, or restart one you stopped for at least two weeks.
- You are not taking medications that strongly affect your immune system (like steroids or certain antibody treatments) in the last 4 weeks.
- You are able to have blood tests (and possibly a spinal tap, depending on the study part).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a probiotic supplement can help reduce metabolic side effects (like weight gain or high blood sugar) caused by antipsychotic medications. It is for people with psychosis who are on stable treatment.
This trial tests whether clozapine, a medication for psychosis in Parkinson's disease, affects the immune system. It involves regular blood monitoring to help keep patients safe.
This study tests whether doing resistance (strength) training at specific times of day can help protect against the weight gain and metabolic changes often caused by antipsychotic medicines. It is for people who have just started antipsychotic treatment for a first episode of psychosis.
This study looks at “biomarkers,” or blood measures, in people with schizophrenia who respond to clozapine. It may help researchers understand who benefits from clozapine and why, by linking test results to symptom changes.
This study looks at how the brain processes information in people with early psychosis compared to healthy controls. It may help improve understanding and treatment of psychosis.
This study looks at whether the immune system might be causing or contributing to brain and mental health symptoms. It involves blood tests and possibly a spinal fluid test, and aims to better understand these conditions to improve future treatments.
Hear when a new Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.